Tech Company Financing Transactions
Intra-Cellular Therapies Funding Round
Private investors invested in a $70.3 million funding round for Intra-Cellular Therapies. The financing round was announced on 9/12/2013.
Transaction Overview
Company Name
Announced On
9/12/2013
Transaction Type
Venture Equity
Amount
$70,308,475
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
430 East 29th St.
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Email Address
Overview
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sharon Mates
Chief Financial Officer
Lawrence Hineline
VP - Bus. Development
Allen Fienberg
VP - Engineering
Juan Sanchez
Browse more venture capital transactions:
Prev: 9/12/2013: FiscalNote venture capital transaction
Next: 9/12/2013: Okta venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs